City

Bethesda (1)

Condition

Hypoplastic MDS (1)

Severe Aplastic Anemia (1)

Single Lineage Cytopenias, T-LGL (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

National Heart, Lung, and Blood Institute (NHLBI) (1)

Collaborator

Intervention

ruxolitinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

hypoplastic mds

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood

Not yet recruiting

Severe Aplastic Anemia
+2 more

Ruxolitinib

Bethesda, Maryland

National Institutes of Health Clinical Center

Aug 23, 2023